Literature DB >> 2986854

Products of the lipoxygenase pathway in human natural killer cell cytotoxicity.

P Rossi, J A Lindgren, C Kullman, M Jondal.   

Abstract

As earlier data suggested the importance of lipoxygenase activation for expression of human NK cell cytotoxicity, four different lipoxygenase inhibitors were tested for suppression of natural killer (NK) cell lysis. All inhibitors were found active at nontoxic concentrations with 50% inhibition at approximately 15 microM for nordihydroguaiaretic acid (NDGA). NK cell lysis could be reconstituted to NDGA-suppressed cells with leukotriene B4 (LTB4), the all-trans isomers 6-trans-LTB4 and 12-epi-6-trans-LTB4, and 20-COOH-LTB4. LTB4 reconstitution was best in the concentration range 1-100 pM and near control levels at both higher and lower concentrations. Herpesvirus Ateles-transformed killer T cells could also be inhibited by NDGA. These data indicate that lipoxygenase activity is required for human NK cell lysis and that several different LTB4-related products can restore NK activity in inhibited cells; they also suggest that the lipoxygenase pathway is present in the killer cell population.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2986854     DOI: 10.1016/0008-8749(85)90383-1

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  5 in total

1.  Fc receptor triggering induces expression of surface activation antigens and release of platelet-activating factor in large granular lymphocytes.

Authors:  F Malavasi; C Tetta; A Funaro; G Bellone; E Ferrero; A C Franzone; P Dellabona; R Rusci; L Matera; G Camussi
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

2.  Modulation of natural killing by cyclo- and lipo-oxygenase inhibitors.

Authors:  M L Villa; F Valenti; M Mantovani
Journal:  Immunology       Date:  1988-01       Impact factor: 7.397

3.  Raloxifene and antiestrogenic gonadorelin inhibits intestinal tumorigenesis by modulating immune cells and decreasing stem-like cells.

Authors:  Naveena B Janakiram; Altaf Mohammed; Misty Brewer; Taylor Bryant; Laura Biddick; Stan Lightfoot; Gopal Pathuri; Hariprasad Gali; Chinthalapally V Rao
Journal:  Cancer Prev Res (Phila)       Date:  2014-01-15

Review 4.  The metabolic advantage of tumor cells.

Authors:  Maurice Israël; Laurent Schwartz
Journal:  Mol Cancer       Date:  2011-06-07       Impact factor: 27.401

5.  Cytosolic PLA2 is required for CTL-mediated immunopathology of celiac disease via NKG2D and IL-15.

Authors:  Fangming Tang; Zhangguo Chen; Cezary Ciszewski; Mala Setty; Jason Solus; Maria Tretiakova; Ellen Ebert; Jin Han; Anning Lin; Stefano Guandalini; Veronika Groh; Thomas Spies; Peter Green; Bana Jabri
Journal:  J Exp Med       Date:  2009-02-23       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.